Replies to post #52159 on Cytogenix (fka CYGX)

[knowledge]

Funny stuff.

I don't question the science, because of the results that we have heard from companies such as Aldevron. The problem may simply be that the science may be excellent, but if you are offering something that companies are not yet convinced of, nobody is going to buy it.

Potentially our marketing efforts are lacking, since presumably the demand exists - if it is cheaper and more pure. A friend of mine works for a bio pharma who simply outsourced the sales component, since they didn't have the talent or money, and it resulted in success for the company. Maybe this is something CYGX looks into to try to produce revenue in the US (I believe they are utilizing Eurogentec, or something like that, over-seas).